← Back to Search

Carotenoid

Lutein for Multiple Sclerosis (LuMES Trial)

N/A
Waitlist Available
Led By Naiman Khan, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months (baseline vs. follow-up)
Awards & highlights

LuMES Trial Summary

This trial is testing whether lutein supplements can improve eyesight and cognition in people with multiple sclerosis.

Eligible Conditions
  • Multiple Sclerosis

LuMES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months (baseline vs. follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months (baseline vs. follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attentional Accuracy
Attentional Processing Speed
Attentional Reaction Time
+2 more

Side effects data

From 2008 Phase 3 trial • 240 Patients • NCT00346333
1%
Death
100%
80%
60%
40%
20%
0%
Study treatment Arm
Control Plus Vitamin A
Lutein Plus Vitamin A

LuMES Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: LuteinExperimental Treatment1 Intervention
Group II: Safflower OilPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lutein
2016
Completed Phase 3
~550

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,275 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
625 Patients Enrolled for Multiple Sclerosis
Division of Nutritional Sciences, University of Illinois at Urbana-ChampaignUNKNOWN
1 Previous Clinical Trials
23 Total Patients Enrolled
National Institutes of Health Rehabilitation Research Resource to Enhance Clinical Trials (REACT)UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age cap when it comes to enrolling in this research program?

"The parameters of this trial necessitate that all participants are between the ages of 18 and 64. In contrast, 44 other trials cater to those younger than 18 while 392 focus on individuals aged 65 or older."

Answered by AI

Is there an eligibility requirement to join this research endeavor?

"In order to qualify for this clinical trial, the individual must have a diagnosis of multiple sclerosis and be between 18-64 years old. The total number of participants being accepted is 60."

Answered by AI

Is recruitment for this research project still underway?

"Per clinicaltrials.gov, this investigation is currently searching for participants. It was initially listed on March 26th 2021 and the latest update to the trial was made April 12th 2021."

Answered by AI

What is the maximum number of participants in this experiment?

"Affirmative. According to the data available on clinicaltrials.gov, this trial is recruiting participants and was originally published on March 26th 2021 with its most recent update being posted in April 12th 2021. This study requires 60 individuals from one site location for completion."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
How old are they?
18 - 65
What site did they apply to?
University of Illinois at Urbana-Champaign
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-
Naiman Khan 2021. "Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04843813.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top